Frank Kung - Sep 15, 2022 Form 4 Insider Report for AMYRIS, INC. (AMRS)

Role
Director
Signature
/s/ Frank Kung by Bruna Lawant Attorney-in-Fact
Stock symbol
AMRS
Transactions as of
Sep 15, 2022
Transactions value $
-$12,922,729
Form type
4
Date filed
9/19/2022, 09:00 PM
Previous filing
Aug 29, 2022
Next filing
Sep 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMRS Common Stock Sale -$4.76M -1.13M -35.52% $4.20 2.06M Sep 15, 2022 by Vivo Opportunity Fund Holdings, LP F1, F2, F3
transaction AMRS Common Stock Sale -$1.06M -253K -35.52% $4.20 459K Sep 15, 2022 by Vivo Capital Fund IX, LP F1, F2, F4
transaction AMRS Common Stock Sale -$2.45M -681K -33.14% $3.60 1.37M Sep 16, 2022 by Vivo Opportunity Fund Holdings, LP F1, F3, F5
transaction AMRS Common Stock Sale -$547K -152K -33.14% $3.60 307K Sep 16, 2022 by Vivo Capital Fund IX, LP F1, F4, F5
transaction AMRS Common Stock Sale -$3.36M -884K -64.3% $3.80 491K Sep 19, 2022 by Vivo Opportunity Fund Holdings, LP F1, F3, F6
transaction AMRS Common Stock Sale -$749K -197K -64.3% $3.80 109K Sep 19, 2022 by Vivo Capital Fund IX, LP F1, F4, F6
holding AMRS Common Stock 6.8M Sep 15, 2022 by Vivo Capital Fund VIII, L.P. F7
holding AMRS Common Stock 938K Sep 15, 2022 by Vivo Capital Surplus Fund VIII, L.P. F7
holding AMRS Common Stock 16.2K Sep 15, 2022 by Vivo Capital LLC F8
holding AMRS Common Stock 80K Sep 15, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by each of Vivo Capital Fund IX, L.P. and Vivo Opportunity Fund Holdings, L.P. on August 15, 2022.
F2 The price reported herein is a weighted average price. These shares were sold on the open market in multiple transactions at prices ranging from $3.60 to $4.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
F3 The General Partner of Vivo Opportunity Fund Holdings, L.P. is Vivo Opportunity, LLC, of which the Reporting Person is a voting member. The Reporting Person may be deemed to share voting and dispositive power over these shares with four (4) other voting members. The Reporting Person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
F4 The General Partner of Vivo Capital Fund IX, L.P. is Vivo Capital IX, LLC, of which the Reporting Person is a voting member. The Reporting Person may be deemed to share voting and dispositive power over these shares with six (6) other voting members. The Reporting Person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
F5 The price reported herein is a weighted average price. These shares were sold on the open market in multiple transactions at prices ranging from $3.50 to $3.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (5) to this Form 4.
F6 The price reported herein is a weighted average price. These shares were sold on the open market in multiple transactions at prices ranging from $3.40 to $4.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (6) to this Form 4.
F7 The General Partner of Vivo Capital Fund VIII, L.P. and Vivo Capital Surplus Fund VIII, L.P. is Vivo Capital VIII, LLC, of which the Reporting Person is a voting member. The Reporting Person may be deemed to share voting and dispositive power over these shares with four (4) other voting members. The Reporting Person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
F8 Pursuant to an agreement dated November 2, 2017 between the Reporting Person and Vivo Capital LLC ("Vivo Capital"), the Reporting Person agreed to remit the equity compensation received under Issuer's non-employee director compensation program to Vivo Capital if and when such equity compensation becomes vested and/or exercised.